Publication | Open Access
Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy
33
Citations
33
References
2015
Year
The SOX regimen could be a neoadjuvant chemotherapy for advanced gastric cancer worldwide in the future.
| Year | Citations | |
|---|---|---|
Page 1
Page 1